Emergence of hepatitis C virus genotype 4: Phylogenetic analysis reveals three distinct epidemiological profiles

Journal of Clinical Microbiology

Volumn 47, Issue 12, 2009, Pages 3832-3838

  De Bruijne, Joep ^a   Schinkel, Janke ^a   Prins, Maria ^a,b   Koekkoek, Sylvie M ^a   Aronson, Sem J ^a   Van Ballegooijen, Marijn W ^c   Reesink, Hendrik W ^a   Molenkamp, Richard ^a   Van De Laar, Thijs J W ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Amsterdam Health Service   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTRUCTURAL PROTEIN 5B;

ARTICLE; EUROPE; EVOLUTION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C VIRUS; HIGH RISK BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INTRAVENOUS DRUG ABUSE; MALE HOMOSEXUAL; MOLECULAR CLOCK; MOLECULAR EPIDEMIOLOGY; MONOPHYLY; NETHERLANDS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; SEXUAL BEHAVIOR; VIRUS STRAIN;

EVOLUTION, MOLECULAR; GENETIC VARIATION; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; NETHERLANDS; PHYLOGENY; SEQUENCE ANALYSIS, DNA;

HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 4; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 71549168619     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01146-09     Document Type: Article

References (36)

1. Alter, M. J. 2002. Prevention of spread of hepatitis C. Hepatology 36:S93-S98.
2. Ansaldi, F., B. Bruzzone, S. Salmaso, M. C. Rota, P. Durando, R. Gasparini, and G. Icardi. 2005. Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J. Med. Virol. 76:327-332.
3. Beld, M., R. Minnaar, J. Weel, C. Sol, M. Damen, H. van der Avoort, P. Wertheim-van Dillen, A. van Breda, and R. Boom. 2004. Highly sensitive assay for detection of enterovirus in clinical specimens by reverse transcription-PCR with an armored RNA internal control. J. Clin. Microbiol. 42:3059-3064.
4. Danta, M., D. Brown, S. Bhagani, O. G. Pybus, C. A. Sabin, M. Nelson, M. Fisher, A. M. Johnson, and G. M. Dusheiko. 2007. Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. AIDS 21:983-991. (Pubitemid 46684329)
5. Delwaide, J., C. Reenaers, C. Gerard, D. Vaira, B. Bastens, B. Servais, A. Bekhti, C. Bataille, E. Wain, P. De Leeuw, et al. 2006. HCV genotype 4 in Belgium: three distinct patterns among patients from European and African origin. Eur. J. Gastroenterol. Hepatol. 18:707-712.
6. de Vries, M. J., B. te Rijdt, and C. M. van Nieuwkerk. 2006. Genotype distribution amongst hepatitis C patients in The Netherlands. Neth. J. Med. 64:109-113.
7. Frank, C., M. K. Mohamed, G. T. Strickland, D. Lavanchy, R. R. Arthur, L. S. Magder, T. El Khoby, Y. Abdel-Wahab, E. S. Aly Ohn, W. Anwar, and I. Sallam. 2000. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355:887-891. (Pubitemid 30137669)
8. Giraudon, I., M. Ruf, H. Maguire, A. Charlett, F. Ncube, J. Turner, R. Gilson, M. Fisher, S. Bhagani, M. Johnson, and S. Barton. 2008. Increase in diagnosed newly acquired hepatitis C in HIV-positive men who have sex with men across London and Brighton, 2002-2006: is this an outbreak? Sex Transm. Infect. 84:111-115.
9. Guindon, S., and O. Gascuel. 2003. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst. Biol. 52:696-704.
10. Kamal, S. M., and I. A. Nasser. 2008. Hepatitis C genotype 4: what we know and what we don't yet know. Hepatology 47:1371-1383.
11. Lauer, G. M., and B. D. Walker. 2001. Hepatitis C virus infection. N. Engl. J. Med. 345:41-52.
12. Morice, Y., D. Roulot, V. Grando, J. Stirnemann, E. Gault, V. Jeantils, M. Bentata, B. Jarrousse, O. Lortholary, C. Pallier, and P. Deny. 2001. Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis District (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns. J. Gen. Virol. 82:1001-1012.
13. Murphy, D. G., B. Willems, M. Deschenes, N. Hilzenrat, R. Mousseau, and S. Sabbah. 2007. Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5′ untranslated region sequences. J. Clin. Microbiol. 45:1102-1112.
14. Nicot, F., F. Legrand-Abravanel, K. Sandres-Saune, A. Boulestin, M. Dubois, L. Alric, J. P. Vinel, C. Pasquier, and J. Izopet. 2005. Heterogeneity of hepatitis C virus genotype 4 strains circulating in south-western France. J. Gen. Virol. 86:107-114.
15. Nylander, J. A., F. Ronquist, J. P. Huelsenbeck, and J. L. Nieves-Aldrey. 2004. Bayesian phylogenetic analysis of combined data. Syst. Biol. 53:47-67.
16. Payan, C., F. Roudot-Thoraval, P. Marcellin, N. Bled, G. Duverlie, I. Fouchard-Hubert, P. Trimoulet, P. Couzigou, D. Cointe, C. Chaput, C. Henquell, et al. 2005. Changing of hepatitis C virus genotype patterns in France at the beginning of the third millennium. J. Viral Hepat. 12:405-413. (Pubitemid 40961481)
17. Poynard, T., M. F. Yuen, V. Ratziu, and C. L. Lai. 2003. Viral hepatitis C. Lancet 362:2095-2100.
18. Pybus, O. G., M. A. Charleston, S. Gupta, A. Rambaut, E. C. Holmes, and P. H. Harvey. 2001. The epidemic behavior of the hepatitis C virus. Science 292:2323-2325.
19. Pybus, O. G., A. Cochrane, E. C. Holmes, and P. Simmonds. 2005. The hepatitis C virus epidemic among injecting drug users. Infect. Genet. Evol. 5:131-139.
20. Pybus, O. G., A. J. Drummond, T. Nakano, B. H. Robertson, and A. Rambaut. 2003. The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: a Bayesian coalescent approach. Mol. Biol. Evol. 20:381-387.
21. Rambaut, A. 2000. Estimating the rate of molecular evolution: incorporating non-contemporaneous sequences into maximum likelihood phylogenies. Bioinformatics 16:395-399. (Pubitemid 30417084)
22. Ray, S. C., R. R. Arthur, A. Carella, J. Bukh, and D. L. Thomas. 2000. Genetic epidemiology of hepatitis C virus throughout Egypt. J. Infect. Dis. 182:698-707.
23. Roy, K., G. Hay, R. Andragetti, A. Taylor, D. Goldberg, and L. Wiessing. 2002. Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature. Epidemiol. Infect. 129:577-585.
24. Sanchez-Quijano, A., M. A. Abad, R. Torronteras, C. Rey, J. A. Pineda, M. Leal, J. Macias, and E. Lissen. 1997. Unexpected high prevalence of hepatitis C virus genotype 4 in southern Spain. J. Hepatol. 27:25-29. (Pubitemid 27357050)
25. Schroter, M., B. Zollner, P. Schafer, A. Reimer, M. Muller, R. Laufs, and H. H. Feucht. 2002. Epidemiological dynamics of hepatitis C virus among 747 German individuals: new subtypes on the advance. J. Clin. Microbiol. 40:1866-1868.
26. Serpaggi, J., M. L. Chaix, D. Batisse, C. Dupont, A. Vallet-Pichard, H. Fontaine, J. P. Viard, C. Piketty, E. Rouveix, C. Rouzioux, L. Weiss, and S. Pol. 2006. Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy. AIDS 20:233-240.
27. Simmonds, P., J. Bukh, C. Combet, G. Deleage, N. Enomoto, S. Feinstone, P. Halfon, G. Inchauspe, C. Kuiken, G. Maertens, et al. 2005. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42:962-973. (Pubitemid 41401136)
28. Smith, D. B., S. Pathirana, F. Davidson, E. Lawlor, J. Power, P. L. Yap, and P. Simmonds. 1997. The origin of hepatitis C virus genotypes. J. Gen. Virol. 78(Pt 2):321-328.
29. Urbanus, A. T., T. J. van de Laar, I. G. Stolte, J. Schinkel, T. Heijman, R. A. Coutinho, and M. Prins. 2009. Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. AIDS 23:F1-F7.
30. van Asten, L., I. Verhaest, S. Lamzira, I. Hernandez-Aguado, R. Zangerle, F. Boufassa, G. Rezza, B. Broers, J. R. Robertson, R. P. Brettle, et al. 2004. Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis. J. Infect. Dis. 189:292-302.
31. van de Laar, T., O. Pybus, S. Bruisten, D. Brown, M. Nelson, S. Bhagani, M. Vogel, A. Baumgarten, M. L. Chaix, M. Fisher, et al. 2009. Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology 136:1609-1617.
32. van de Laar, T. J., M. H. Koppelman, A. K. van der Bij, H. L. Zaaijer, H. T. Cuijpers, C. L. van der Poel, R. A. Coutinho, and S. M. Bruisten. 2006. Diversity and origin of hepatitis C virus infection among unpaid blood donors in The Netherlands. Transfusion 46:1719-1728. (Pubitemid 44435724)
33. van de Laar, T. J., M. W. Langendam, S. M. Bruisten, E. A. Welp, I. Verhaest, E. J. van Ameijden, R. A. Coutinho, and M. Prins. 2005. Changes in risk behavior and dynamics of hepatitis C virus infections among young drug users in Amsterdam, The Netherlands. J. Med. Virol. 77:509-518.
34. van de Laar, T. J., R. Molenkamp, C. van den Berg, J. Schinkel, M. G. Beld, M. Prins, R. A. Coutinho, and S. M. Bruisten. 2009. Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam. J. Hepatol. 51:667-674.
35. van den Berg, C., C. Smit, G. Van Brussel, R. Coutinho, and M. Prins. 2007. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. Addiction 102:1454-1462.
36. van den Berg, C. H., C. Smit, M. Bakker, R. B. Geskus, B. Berkhout, S. Jurriaans, R. A. Coutinho, K. C. Wolthers, and M. Prins. 2007. Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users. Eur. J. Epidemiol. 22:183-193.